» Authors » Caelan Taggart

Caelan Taggart

Explore the profile of Caelan Taggart including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 17
Citations 114
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Boeddinghaus J, Bularga A, Taggart C, Wereski R, McDermott M, Thurston A, et al.
Eur Heart J Acute Cardiovasc Care . 2025 Jan; PMID: 39824208
Aim: The diagnostic criteria for type 2 myocardial infarction identify a heterogenous group of patients with variable outcomes and no clear treatment implications. We aimed to determine the implications of...
2.
Chapman A, Taggart C, Boeddinghaus J, Mills N, Fox K
Eur Heart J . 2024 Dec; 46(6):504-517. PMID: 39658094
The Fourth Universal Definition of Myocardial Infarction recommends a classification based on aetiology, in recognition that the underlying pathophysiology of myocardial infarction influences the approach to investigation and treatment. Type...
3.
Lowry M, Kimenai D, Doudesis D, Georgiev K, McDermott M, Bularga A, et al.
Age Ageing . 2024 Jul; 53(7). PMID: 39011637
Background: Frailty is increasingly present in patients with acute myocardial infarction. The electronic Frailty Index (eFI) is a validated method of identifying vulnerable older patients in the community from routine...
4.
Wang K, Taggart C, McDermott M, OBrien R, Oatey K, Keating L, et al.
Emerg Med J . 2024 Jun; 41(8):488-494. PMID: 38857986
Background: The HEART score, the T-MACS model and the GRACE score support early decision-making for acute chest pain, which could be complemented by CT coronary angiography (CTCA). However, their performance...
5.
Taggart C, Roos A, Kadesjo E, Anand A, Li Z, Doudesis D, et al.
JAMA Netw Open . 2024 Apr; 7(4):e245853. PMID: 38587840
Importance: Whether the diagnostic classifications proposed by the universal definition of myocardial infarction (MI) to identify type 1 MI due to atherothrombosis and type 2 MI due to myocardial oxygen...
6.
Lee K, Doudesis D, Ferry A, Chapman A, Kimenai D, Fujisawa T, et al.
BMJ . 2023 Nov; 383:e075009. PMID: 38011922
Objective: To evaluate the impact of implementing a high sensitivity assay for cardiac troponin I on long term outcomes in patients with suspected acute coronary syndrome. Design: Secondary observational analysis...
7.
Wereski R, Adamson P, Shek Daud N, McDermott M, Taggart C, Bularga A, et al.
J Am Coll Cardiol . 2023 Aug; 82(6):473-485. PMID: 37532417
Background: Cardiac troponin is used for risk stratification of patients with acute coronary syndromes; however, the role of testing in other settings remains unclear. Objectives: The aim of this study...
8.
Lowry M, Doudesis D, Boeddinghaus J, Kimenai D, Bularga A, Taggart C, et al.
Eur Heart J . 2023 Jun; 44(30):2846-2858. PMID: 37350492
Aims: Whether a single cardiac troponin measurement can safely rule out myocardial infarction in patients presenting within a few hours of symptom onset is uncertain. The study aim was to...
9.
Lee K, Lowe D, OBrien R, Wereski R, Bularga A, Taggart C, et al.
Trials . 2023 Jun; 24(1):402. PMID: 37312104
Background: The majority of patients with suspected acute coronary syndrome presenting to the emergency department will be discharged once myocardial infarction has been ruled out, although a proportion will have...
10.
Taggart C, Monterrubio-Gomez K, Roos A, Boeddinghaus J, Kimenai D, Kadesjo E, et al.
J Am Coll Cardiol . 2023 Jan; 81(2):156-168. PMID: 36631210
Background: Despite poor cardiovascular outcomes, there are no dedicated, validated risk stratification tools to guide investigation or treatment in type 2 myocardial infarction. Objectives: The goal of this study was...